NR082 injection

DRUG2 trials

Sponsors

Wuhan Neurophth Biotechnology Limited Company, Neurophth Therapeutics Inc

Conditions

Leber Hereditary Optic Neuropathy (LHON)Leber's Hereditary Optic Neuropathy (LHON)

Phase 1

Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations

Active, not recruitingNCT05293626

Neurophth Therapeutics IncLeber Hereditary Optic Neuropathy (LHON)

Start: 2023-05-22End: 2029-12-31Updated: 2024-09-04

Phase 2

Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy

RecruitingNCT04912843

Wuhan Neurophth Biotechnology Limited CompanyLeber's Hereditary Optic Neuropathy (LHON)

Start: 2021-06-18End: 2028-02-29Target: 102Updated: 2022-11-14